Quest Diagnostics Incorporated

Symbol: DGX     Sector: Healthcare     Industry: Medical Diagnostics & Research

Dividend Yield
2.09%
Current Price
$101.48
Info     Dividend Rate History     Earnings     Financials     Rankings

Financials 2019

Update: 2019-06-09 17:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 1

2019-03-31
1,891,000,000
1,891,000,000
1,244,000,000
647,000,000
399,000,000
248,000,000
164,000,000
1,778,000,000
11,937,000,000
6,596,000,000
5,290,000,000
464,000,000
1,108,000,000
464,000,000
4,239,000,000
329,000,000
275,000,000
 
-

Financials 2018

Update: 2019-06-09 17:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2018-12-31
1,839,000,000
1,839,000,000
1,235,000,000
604,000,000
380,000,000
224,000,000
127,000,000
1,390,000,000
11,003,000,000
5,736,000,000
5,216,000,000
135,000,000
464,000,000
135,000,000
3,893,000,000
-128,000,000
295,000,000
 
-

Q 3

2018-09-30
1,889,000,000
1,889,000,000
1,222,000,000
667,000,000
363,000,000
304,000,000
213,000,000
1,603,000,000
10,986,000,000
5,621,000,000
5,317,000,000
263,000,000
304,000,000
263,000,000
3,698,000,000
131,000,000
402,000,000
 
-

Q 2

2018-06-30
1,919,000,000
1,919,000,000
1,243,000,000
676,000,000
371,000,000
305,000,000
219,000,000
1,415,000,000
10,747,000,000
5,484,000,000
5,223,000,000
132,000,000
305,000,000
132,000,000
3,713,000,000
8,000,000
323,000,000
 
-

Q 1

2018-03-31
1,884,000,000
1,884,000,000
1,226,000,000
658,000,000
386,000,000
272,000,000
177,000,000
1,371,000,000
10,695,000,000
5,629,000,000
5,030,000,000
124,000,000
141,000,000
124,000,000
3,859,000,000
-13,000,000
180,000,000
 
-

Financials 2017

Update: 2019-06-09 17:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2017-12-31
2,172,000,000
2,172,000,000
1,194,000,000
978,000,000
709,000,000
269,000,000
254,000,000
1,306,000,000
10,503,000,000
5,548,000,000
4,921,000,000
137,000,000
36,000,000
137,000,000
3,784,000,000
-188,000,000
323,000,000
 
-